Skip to content

Clinical trials

Phase 1/2 Endometrial Neoplasms trials in Germany

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Endometrial Neoplasms Phase: Phase 1/2 Country / region: Germany Clear all

11 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20011
20162
20191
20201
20233
20241
20251
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Recruiting7
Completed3
Suspended1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
AGO Study Group1
AstraZeneca1
BioNTech SE1
Clovis Oncology, Inc.1
Daiichi Sankyo1
Eikon Therapeutics1
Eli Lilly and Company1
Novartis Pharmaceuticals1
PMV Pharmaceuticals, Inc1
PharmaMar1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Endometrial Neoplasms11
Ovarian Neoplasms8
Colorectal Neoplasms5
Uterine Cervical Neoplasms4
Neoplasm Metastasis3
Neoplasms3
Breast Neoplasms2
Carcinoma, Non-Small-Cell Lung2
Fallopian Tube Neoplasms2
Head and Neck Neoplasms2

Trials

Showing 1 to 11 of 11. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.